Cue Biopharma, Inc. Soared
Mon, Apr 20, 2026 at 07:21 PM
Cue Biopharma, Inc. (CUE:NASDAQ) soared at $0.85, a gain of 40.2%. On Mon, Apr 20, 2026, CUE:NASDAQ hit a New 2-Week High of $0.85. The stock appeared on our News Catalysts scanner on Wed, Apr 15, 2026 at 10:19 AM in the 'BIOTECH' category. From Mon, Apr 06, 2026, the stock recorded 60.00% Up Days and 63.64% Green Days
About Cue Biopharma, Inc. (CUE:NASDAQ)
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Top 10 Gainers:
- Enveric Biosciences, Inc. (ENVB:NASDAQ), 100.55%
- Hempacco Co., Inc. (HPCO:NASDAQ), 100%
- Theriva Biologics, Inc. (TOVX:NYSEMKT), 59.41%
- FGI Industries Ltd. (FGI:NASDAQ), 50.62%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 48.68%
- Julong Holding Limited (JLHL:NASDAQ), 48.66%
- COMPASS Pathways plc (CMPS:NASDAQ), 42.04%
- CN Energy Group. Inc. (CNEY:NASDAQ), 41.59%
- Beyond Meat, Inc. (BYND:NASDAQ), 41.02%
- Cue Biopharma, Inc. (CUE:NASDAQ), 40.15%